|
Market Closed -
Nasdaq
06:00:00 03/10/26 am AEST
|
5-day change | 1st Jan Change | ||
| 735.20 USD | +0.05% |
|
-6.71% | -4.75% |
| 02/10 | Jefferies Raises Regeneron Pharmaceuticals Price Target to $930 From $870, Maintains Buy Rating | MT |
| 02/10 | Major drugmakers turn to China for licensing deals | RE |
| Market Cap | 73.41B 65.24B 60.79B 55.43B 105B 7,070B 106B 737B 286B 3,603B 276B 270B 11,573B | P/E 2026 * |
16.8x | P/E 2027 * | 14.5x |
|---|---|---|---|---|---|
| Enterprise Value | 65.99B 58.64B 54.64B 49.83B 94.05B 6,355B 94.92B 662B 257B 3,238B 248B 242B 10,403B | EV / Sales 2026 * |
3.88x | EV / Sales 2027 * | 3.41x |
| Free-Float |
71.06% | Yield 2026 * |
0.53% | Yield 2027 * | 0.6% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| REGN | Delayed | |
CBOE
| REGN | Real-time | |
|
Tradegate
| RGO | Real-time | |
|
Mexican S.E.
| REGN * | End-of-day quote | |
|
Boerse Muenchen
| RGO | Real-time | |
|
Deutsche Boerse AG
| RGO | Delayed | |
|
Xetra
| RGO | End-of-day quote | |
|
London S.E.
| 0R2M | Delayed | |
|
Wiener Boerse
| REGN | End-of-day quote | |
|
Börse Stuttgart
| RGO | Delayed | |
|
Borsa Italiana
| 1REGN | End-of-day quote | |
|
Lima
| REGNUS | End-of-day quote |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | +0.05% | ||
| 1 week | -6.71% | ||
| Current month | -3.04% | ||
| 1 month | -11.18% | ||
| 3 months | +12.37% | ||
| 6 months | -3.50% | ||
| Current year | -4.75% |
| 1 week | 726.02 |  | 777.43 |
| 1 month | 726.02 | | 821.17 |
| Current year | 591.52 | | 859.34 |
| 1 year | 541 | | 859.34 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 01/01/2001 | |
| Chief Executive Officer | 73 | 08/01/1988 | |
| Director of Finance/CFO | 55 | 05/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 09/06/2023 | |
Joseph Goldstein
BRD | Director/Board Member | 85 | 01/06/1991 |
George Sing
BRD | Director/Board Member | 76 | 08/01/1988 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/9/26 | Sell | Executive/Senior Manager | -1,131 | 0.0011% | ||
| 2/9/26 | Exercice | Director | 1,200 | 0.0012% | ||
| 19/8/26 | Exercice | General Counsel | 33,583 | 0.0326% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.05% | -6.71% | +22.53% | -9.79% | 73.41B | |
| -0.61% | -3.43% | +36.07% | +115.04% | 1,019B | |
| -1.02% | -5.60% | +35.72% | +64.63% | 617B | |
| +1.11% | -0.58% | +12.36% | +77.95% | 464B | |
| +0.34% | -3.01% | +61.79% | +41.24% | 356B | |
| -0.95% | -4.05% | +20.54% | +40.33% | 333B | |
| -1.46% | -2.89% | +10.57% | +26.54% | 267B | |
| -1.35% | -5.43% | -6.17% | +8.82% | 244B | |
| -1.04% | -2.79% | +35.30% | +51.84% | 218B | |
| -1.87% | -4.10% | +28.44% | +93.66% | 179B | |
| Average | -0.68% | -3.72% | +25.72% | +51.03% | 377.06B | |
| Weighted average by Cap. | -0.59% | -3.39% | +28.95% | +68.43% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 17.01B 15.12B 14.09B 12.85B 24.25B 1,638B 24.47B 171B 66.2B 835B 63.87B 62.48B 2,682B | 18.51B 16.45B 15.33B 13.98B 26.38B 1,783B 26.63B 186B 72.03B 908B 69.5B 67.98B 2,918B |
| Net income | 4.95B 4.4B 4.1B 3.74B 7.06B 477B 7.12B 49.68B 19.27B 243B 18.59B 18.18B 781B | 5.49B 4.87B 4.54B 4.14B 7.82B 528B 7.89B 55.04B 21.34B 269B 20.59B 20.15B 865B |
| Net Debt | -7.42B -6.6B -6.15B -5.6B -10.58B -715B -10.68B -74.46B -28.88B -364B -27.86B -27.26B -1,170B | -10.32B -9.17B -8.54B -7.79B -14.7B -993B -14.84B -103B -40.14B -506B -38.73B -37.88B -1,626B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/10/26 | USD 735.20 | +0.05% | 613,949 |
| 01/10/26 | USD 734.81 | -3.09% | 1,042,865 |
| 30/09/26 | USD 758.27 | +1.03% | 872,457 |
| 29/09/26 | USD 750.51 | -0.23% | 804,336 |
| 28/09/26 | USD 752.25 | -4.54% | 1,149,832 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
